MicroRNA MIR214: Potential Drug Target Or Biomarker for Various Diseases
MicroRNA MIR214: Potential Drug Target Or Biomarker for Various Diseases
MIR214 (hsa-miR-214-3p) is a microRNA (miRNA) that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
MIR214 is a non-coding RNA molecule that contains 214 base pairs and is located in the hsa-miR gene cluster on chromosome 12. It is expressed in a variety of tissues and cells throughout the body and is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.
One of the key functions of MIR214 is its role in cell apoptosis. MIR214 has been shown to play a role in the regulation of cell death, and it has been shown to induce apoptosis in a variety of cell types when exposed to certain stressors, such as chemotherapy drugs or UV radiation.
In addition to its role in cell apoptosis, MIR214 has also been shown to play a role in the regulation of cell proliferation. MIR214 has been shown to inhibit the growth of cancer cells and to promote the growth of healthy cell types.
MIR214 has also been shown to be involved in the regulation of inflammation. MIR214 has been shown to regulate the production of pro-inflammatory cytokines and to inhibit the production of anti-inflammatory cytokines.
MIR214 has also been shown to play a role in the regulation of stem cell maintenance. MIR214 has been shown to promote the self-renewal of stem cells and to inhibit the differentiation of stem cells into different cell types.
MIR214 has also been shown to play a role in the regulation of tissue repair. MIR214 has been shown to promote the healing of wounds and to inhibit the formation of scar tissue.
MIR214 has also been shown to play a role in the regulation of metabolism. MIR214 has been shown to regulate the production of glucose and to inhibit the production of lipids.
MIR214 has also been shown to play a role in the regulation of cellular signaling pathways. MIR214 has been shown to interact with a variety of signaling molecules, including TGF-β, NF-kappa-B, and PI3K.
MIR214 has also been shown to play a role in the regulation of gene expression. MIR214 has been shown to interact with a variety of gene transcripts and to regulate their levels in different cell types.
MIR214 has also been shown to play a role in the regulation of cellular transport. MIR214 has been shown to interact with a variety of cellular transport proteins and to regulate their activity.
MIR214 has also been shown to play a role in the regulation of cellular adhesion. MIR214 has been shown to interact with a variety of adhesion molecules and to regulate their activity.
MIR214 has also been shown to play a role in the regulation of cellular signaling pathways. MIR214 has been shown to interact with a variety of signaling molecules, including TGF-β, NF-kappa-B, and PI3K.
MIR214 has also been shown to play a role in the regulation of gene expression. MIR214 has been shown to interact with a variety of gene transcripts and to regulate their levels in different cell types.
MIR214 has also been shown to play a role in the regulation of cellular transport. MIR214 has been shown to interact with a variety of cellular transport proteins and to regulate their activity.
MIR214 has also been shown to play a role in the regulation of cellular adhesion. MIR214 has been shown to interact with a variety of adhesion molecules and to regulate their activity.
In conclusion, MIR214 is a microRNA that has been shown to play a
Protein Name: MicroRNA 214
The "MIR214 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR214 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136
